Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease al amyloidosis
Comorbidity C0152025|polyneuropathy
Sentences 9
PubMedID- 22941262 Varied clinical presentations are described in transthyretin (ttr)-familial amyloidosis with polyneuropathy (fap) and light chain amyloid neuropathy.
PubMedID- 22620968 Regional difference and similarity of familial amyloidosis with polyneuropathy in france.
PubMedID- 22856884 Purpose: familial amyloidosis with polyneuropathy (fap) sometimes courses with vitreous amyloid.
PubMedID- 22277512 Similar clinical recovery was seen in primary systemic al amyloidosis patients with polyneuropathy after high dose melphalan with auto-pbsct.
PubMedID- 24363850 Systemic amyloidosis has subtypes of light chain (al) amyloidosis, amyloid a (aa) amyloidosis, dialysis-related amyloidosis, hereditary amyloidosis such as familial amyloidosis with polyneuropathy, cardiac or renal amyloidosis, and organ specific amyloidosis such as alzheimer disease, cardiac, laryngeal, or pulmonary amyloidosis [1].
PubMedID- 24970351 Isolated autonomic failure without evident somatic polyneuropathy in al amyloidosis.
PubMedID- 20840742 Background: familial amyloidosis with polyneuropathy (fap) is an autosomal dominant disease caused by transthyretin (ttr) mutations, of which v30m (ttr c.148g > a, p.val50met, "val30met") is the most common.
PubMedID- 26096568 Purpose: assessment of ocular involvement in transthyretin-related familial amyloidosis with polyneuropathy (fap) in a large cohort of portuguese patients.
PubMedID- 22928869 Familial amyloidosis with polyneuropathy associated with ttr ser50arg mutation.

Page: 1